BBC news
UK approves another antibody treatment for Covid Monoclonal antibodies attacking coronavirus The UK has approved another antibody treatment for people with Covid that cuts the risk of severe illness. It's called sotrovimab, and scientists say preliminary checks suggest it should work well even against new variants such as Omicron. The drug, given in a drip into a vein, binds to the virus to stop it entering our cells. In a clinical trial, a single dose reduced the risk of hospitalisation and death by 79% in high risk adults. It is the second drug of its kind - a monoclonal antibody treatment - that UK regulators have approved. Ronapreve antibody treatment for Covid approved in UK Both sotrovimab and the other approved antibody treatment, ronapreve, are most effective when taken during the early stages of infection. The Medicines and Healthcare products Regulatory Agency (MHRA) recommends they are used within five days of someone getting symptoms. Dr June Raine, MHRA chief executive...